Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy.

about

Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity Cyclosporin A-related cerebral venous sinus thrombosis: A case report

P2860

Q38761096-248BD73F-0FB7-4313-B041-EBF2EF11FC44 Q58802049-D1CDF77C-9E07-4AF3-8589-9C9D7C3B056F

P2860

Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy.

Item

http://www.wikidata.org/entity/Q41789033

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy.

@en

type

Item

label

Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy.

@en

prefLabel

Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy.

@en

P1476

Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy.

@en

P2093

Mohammed Bayoumi

http://www.w3.org/2001/XMLSchema#string

Shamshad Gulab

http://www.w3.org/2001/XMLSchema#string

Youssef Alsaid

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombosis of the cerebral veins and sinuses

Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy.

Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Cerebral sinovenous thrombosis. Neuroimaging diagnosis and clinical management.

Thrombosis and acute lymphoblastic leukaemia.

Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.

Cerebral venous sinus (sinovenous) thrombosis in children

Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Sagittal sinus thrombosis due to L-asparaginase.

FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).

P304

841057

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/841057

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Saleh S. Baeesa

P577

2013-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237087550

http://www.w3.org/2001/XMLSchema#string

P698

23781355

http://www.w3.org/2001/XMLSchema#string

P932

3679692

http://www.w3.org/2001/XMLSchema#string

Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy.

about

P2860

P2860

Cerebral Sinus Venous Thrombosis due to Asparaginase Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932